Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2025 Filed Aug 12, 2025 16:51 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
GrantWarrant to Purchase Common Stock · Derivative | 22,344 | Not disclosed Strike: $19.25 | Not disclosed |
DisclosureSEC source: 0001213900-25-075035 · ownership.xml · derivative · entry 5 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,344 Underlying: Common Stock · 22,344 shares Expires 2026-09-27 F4 · security: The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares. F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 16:51 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 22,344 | Not disclosed Strike: $19.25 | Not disclosed |
DisclosureSEC source: 0001213900-25-075035 · ownership.xml · derivative · entry 4 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,344 shares Expires 2025-09-27 F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 16:51 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
GrantWarrant to Purchase Common Stock · Derivative | 31,373 | Not disclosed Strike: $28.75 | Not disclosed |
DisclosureSEC source: 0001213900-25-075035 · ownership.xml · derivative · entry 3 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,373 Underlying: Common Stock · 31,373 shares Expires 2026-08-14 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 16:51 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 31,373 | Not disclosed Strike: $28.75 | Not disclosed |
DisclosureSEC source: 0001213900-25-075035 · ownership.xml · derivative · entry 2 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,373 shares Expires 2025-08-14 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. Read SEC document |
| August 08, 2025 Filed Sep 23, 2025 16:05 UTC |
Mazur Leonard LDirector · Chief Executive Officer
|
GrantWarrant to Purchase Common Stock · Derivative | 89,388 | Not disclosed Strike: $19.25 | Not disclosed |
DisclosureSEC source: 0001213900-25-090602 · ownership.xml · derivative · entry 5 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,388 Underlying: Common Stock · 89,388 shares Expires 2026-09-27 F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. Read SEC document |
| August 08, 2025 Filed Sep 23, 2025 16:05 UTC |
Mazur Leonard LDirector · Chief Executive Officer
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 89,388 | Not disclosed Strike: $19.25 | Not disclosed |
DisclosureSEC source: 0001213900-25-090602 · ownership.xml · derivative · entry 4 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,388 shares Expires 2025-09-27 F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. Read SEC document |
| August 08, 2025 Filed Sep 23, 2025 16:05 UTC |
Mazur Leonard LDirector · Chief Executive Officer
|
GrantWarrant to Purchase Common Stock · Derivative | 125,490 | Not disclosed Strike: $28.75 | Not disclosed |
DisclosureSEC source: 0001213900-25-090602 · ownership.xml · derivative · entry 3 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,490 Underlying: Common Stock · 125,490 shares Expires 2026-08-14 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. Read SEC document |
| August 08, 2025 Filed Sep 23, 2025 16:05 UTC |
Mazur Leonard LDirector · Chief Executive Officer
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 125,490 | Not disclosed Strike: $28.75 | Not disclosed |
DisclosureSEC source: 0001213900-25-090602 · ownership.xml · derivative · entry 2 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,490 shares Expires 2025-08-14 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 17:00 UTC |
Smith Robert JosephDirector
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 125,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096894 · ownership.xml · derivative · entry 1 Smith Robert Joseph · CIK 0002008764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 17:00 UTC |
Czuczman MyronChief Medical Officer
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 300,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096891 · ownership.xml · derivative · entry 1 Czuczman Myron · CIK 0001817716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 17:00 UTC |
Webb CarolDirector
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 125,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096895 · ownership.xml · derivative · entry 2 Webb Carol · CIK 0001671111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 17:00 UTC |
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 600,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096892 · ownership.xml · derivative · entry 2 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 22:00 UTC |
MCGRATH DENNIS MDirector
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 125,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096889 · ownership.xml · derivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 17:00 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096888 · ownership.xml · derivative · entry 3 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-11-07 F2 · derivative.exercise_date: The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares. F2 · ownership.nature: The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 17:00 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 350,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096888 · ownership.xml · derivative · entry 2 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 22:00 UTC |
Bartushak JaimeChief Financial Officer
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 350,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096893 · ownership.xml · derivative · entry 2 Bartushak Jaime · CIK 0001725077 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 22:00 UTC |
Dutia Suren GDirector
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 125,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096890 · ownership.xml · derivative · entry 1 Dutia Suren G · CIK 0001514063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 22:00 UTC |
Holuka Eugene MyronDirector
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 125,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001213900-24-096887 · ownership.xml · derivative · entry 2 Holuka Eugene Myron · CIK 0001678292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-11-07 F1 · derivative.exercise_date: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 17:26 UTC |
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
|
GrantWarrant to Purchase Common Stock · Derivative | 2,234,700 | Not disclosed Strike: $0.77 | Not disclosed |
DisclosureSEC source: 0001213900-24-082812 · ownership.xml · derivative · entry 5 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,234,700 Underlying: Common Stock · 2,234,700 shares Expires 2025-09-27 F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 17:26 UTC |
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 2,234,700 | Not disclosed Strike: $0.77 | Not disclosed |
DisclosureSEC source: 0001213900-24-082812 · ownership.xml · derivative · entry 4 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,234,700 shares Expires 2024-09-27 F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 17:27 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
GrantWarrant to Purchase Common Stock · Derivative | 558,597 | Not disclosed Strike: $0.77 | Not disclosed |
DisclosureSEC source: 0001213900-24-082813 · ownership.xml · derivative · entry 5 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 558,597 Underlying: Common Stock · 558,597 shares Expires 2025-09-27 F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. Read SEC document |
| September 25, 2024 Filed Sep 27, 2024 17:27 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 558,597 | Not disclosed Strike: $0.77 | Not disclosed |
DisclosureSEC source: 0001213900-24-082813 · ownership.xml · derivative · entry 4 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 558,597 shares Expires 2024-09-27 F2 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. F2 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. Read SEC document |
| August 14, 2024 Filed Sep 27, 2024 17:26 UTC |
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
|
GrantWarrant to Purchase Common Stock · Derivative | 3,137,255 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0001213900-24-082812 · ownership.xml · derivative · entry 3 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,137,255 Underlying: Common Stock · 3,137,255 shares Expires 2025-08-14 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. Read SEC document |
| August 14, 2024 Filed Sep 27, 2024 17:26 UTC |
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 3,137,255 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0001213900-24-082812 · ownership.xml · derivative · entry 2 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,137,255 shares Expires 2024-08-14 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. Read SEC document |
| August 14, 2024 Filed Sep 27, 2024 17:27 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
GrantWarrant to Purchase Common Stock · Derivative | 784,314 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0001213900-24-082813 · ownership.xml · derivative · entry 3 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 784,314 Underlying: Common Stock · 784,314 shares Expires 2025-08-14 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. Read SEC document |
| August 14, 2024 Filed Sep 27, 2024 17:27 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 784,314 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0001213900-24-082813 · ownership.xml · derivative · entry 2 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 784,314 shares Expires 2024-08-14 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 16:05 UTC |
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
|
GrantWarrant to Purchase Common Stock · Derivative | 1,165,048 | Not disclosed Strike: $1.42 | Not disclosed |
DisclosureSEC source: 0001213900-24-030811 · ownership.xml · derivative · entry 3 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,165,048 Underlying: Common Stock · 1,165,048 shares Expires 2025-04-05 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 16:05 UTC |
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 1,165,048 | Not disclosed Strike: $1.42 | Not disclosed |
DisclosureSEC source: 0001213900-24-030811 · ownership.xml · derivative · entry 2 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,165,048 shares Expires 2024-04-05 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 16:05 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
GrantWarrant to Purchase Common Stock · Derivative | 129,450 | Not disclosed Strike: $1.42 | Not disclosed |
DisclosureSEC source: 0001213900-24-030812 · ownership.xml · derivative · entry 3 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,450 Underlying: Common Stock · 129,450 shares Expires 2025-04-05 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 16:05 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
Disposition to issuerWarrant to Purchase Common Stock · Derivative | 129,450 | Not disclosed Strike: $1.42 | Not disclosed |
DisclosureSEC source: 0001213900-24-030812 · ownership.xml · derivative · entry 2 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 129,450 shares Expires 2024-04-05 F1 · security: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · kind: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · price: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. F1 · derivative.exercise_date: The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 16:06 UTC |
Smith Robert JosephDirector
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 75,000 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0001213900-24-023487 · ownership.xml · derivative · entry 1 Smith Robert Joseph · CIK 0002008764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-03-12 F1 · derivative.exercise_date: The options were granted on March 14, 2024, with a Vesting Commencement Date of March 12, 2024, the date of the Optionee's election to the Board of the Company. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| March 13, 2024 Filed Aug 30, 2024 20:01 UTC |
Holuka Eugene MyronDirector
|
Exercise / conversionStock Option (Right to Purchase Common Stock) · Derivative | 2,415 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001213900-24-074506 · ownership.xml · derivative · entry 3 Holuka Eugene Myron · CIK 0001678292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,415 shares Expires 2024-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2024 Filed Aug 30, 2024 20:01 UTC |
Holuka Eugene MyronDirector
|
Tax withholdingCommon Stock | 48 | $0.75 | $36.00 |
DisclosureSEC source: 0001213900-24-074506 · ownership.xml · nonDerivative · entry 2 Holuka Eugene Myron · CIK 0001678292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,367 Read SEC document |
| March 13, 2024 Filed Aug 30, 2024 20:01 UTC |
Holuka Eugene MyronDirector
|
Exercise / conversionCommon Stock | 2,415 | $0.02 | $36.23 |
DisclosureSEC source: 0001213900-24-074506 · ownership.xml · nonDerivative · entry 1 Holuka Eugene Myron · CIK 0001678292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Aug 30, 2024 16:01 UTC |
Webb CarolDirector
|
Exercise / conversionStock Option (Right to Purchase Common Stock) · Derivative | 12,071 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001213900-24-074505 · ownership.xml · derivative · entry 3 Webb Carol · CIK 0001671111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,071 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Aug 30, 2024 16:01 UTC |
Webb CarolDirector
|
Tax withholdingCommon Stock | 236 | $0.77 | $180.78 |
DisclosureSEC source: 0001213900-24-074505 · ownership.xml · nonDerivative · entry 2 Webb Carol · CIK 0001671111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,835 Read SEC document |
| March 04, 2024 Filed Aug 30, 2024 16:01 UTC |
Webb CarolDirector
|
Exercise / conversionCommon Stock | 12,071 | $0.02 | $181.07 |
DisclosureSEC source: 0001213900-24-074505 · ownership.xml · nonDerivative · entry 1 Webb Carol · CIK 0001671111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 16:15 UTC |
Czuczman MyronChief Medical Officer
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 300,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001013762-23-003534 · ownership.xml · derivative · entry 1 Czuczman Myron · CIK 0001817716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-10-10 F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 16:15 UTC |
Webb CarolDirector
|
GrantOptions to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001013762-23-003535 · ownership.xml · derivative · entry 1 Webb Carol · CIK 0001671111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-10-10 F1 · security: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 16:15 UTC |
Mazur Leonard LDirector · Chief Executive Officer · 10% owner
|
GrantOption to Purchase Common Stock · Derivative | 550,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001013762-23-003528 · ownership.xml · derivative · entry 13 Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2033-10-10 F10 · security: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. F10 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 20:15 UTC |
MCGRATH DENNIS MDirector
|
GrantOptions to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001013762-23-003529 · ownership.xml · derivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-10-10 F1 · security: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 16:15 UTC |
HOLUBIAK MYRON ZDirector · Vice Chairman
|
GrantOptions to Purchase Common Stock · Derivative | 400,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001013762-23-003533 · ownership.xml · derivative · entry 15 HOLUBIAK MYRON Z · CIK 0001199080 · Director · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2033-10-10 F11 · security: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. F11 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 20:15 UTC |
Holuka Eugene MyronDirector
|
GrantOptions to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001013762-23-003532 · ownership.xml · derivative · entry 1 Holuka Eugene Myron · CIK 0001678292 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-10-10 F1 · security: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 20:15 UTC |
Dutia Suren GDirector
|
GrantOptions to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001013762-23-003531 · ownership.xml · derivative · entry 1 Dutia Suren G · CIK 0001514063 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-10-10 F1 · security: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 20:15 UTC |
Bartushak JaimeChief Financial Officer
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 300,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001013762-23-003530 · ownership.xml · derivative · entry 2 Bartushak Jaime · CIK 0001725077 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-10-10 F1 · security: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date. F1 · derivative.exercise_date: The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 21:06 UTC |
MCGRATH DENNIS MDirector
|
GrantOptions to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001213900-23-009756 · ownership.xml · derivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-02-07 F1 · security: The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. F1 · derivative.exercise_date: The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 16:05 UTC |
Czuczman MyronChief Medical Officer
|
GrantStock Option (Right to Purchase Common Stock) · Derivative | 300,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001213900-22-062472 · ownership.xml · derivative · entry 1 Czuczman Myron · CIK 0001817716 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2032-10-04 F1 · derivative.exercise_date: The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 16:10 UTC |
Kane WilliamDirector
|
GrantOptions to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001213900-22-062485 · ownership.xml · derivative · entry 1 Kane William · CIK 0001671585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-10-04 F1 · security: The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. F1 · derivative.exercise_date: The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 16:06 UTC |
Webb CarolDirector
|
GrantOptions to Purchase Common Stock · Derivative | 75,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001213900-22-062475 · ownership.xml · derivative · entry 1 Webb Carol · CIK 0001671111 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-10-04 F1 · security: The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. F1 · derivative.exercise_date: The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 16:08 UTC |
Mazur Leonard LDirector · Executive Chairman · 10% owner
|
GrantOption to Purchase Common Stock · Derivative | 550,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001213900-22-062481 · ownership.xml · derivative · entry 16 Mazur Leonard L · CIK 0001463414 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2032-10-04 F9 · security: The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. F9 · derivative.exercise_date: The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.